Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with cervical dystonia/spasmodic torticollis for at least 18 months~* Successfully treated previously with botulinum toxin type A~Exclusion Criteria:~* Breast feeding, pregnant, or could become pregnant~* Surgery or spinal cord stimulation for cervical dystonia~* Previous injections of phenol, alcohol for cervical dystonia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- BOTOX® (Type: EXPERIMENTAL): Botulinum toxin type A (BOTOX®)
- Dysport® (Type: ACTIVE_COMPARATOR): Botulinum toxin type A (Dysport®)

Based on this trial design, predict the completion outcome and termination type (if applicable).